Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation

BACKGROUND: Omenn syndrome (OS) is a rare severe combined immunodeficiency associated with autoimmunity and caused by defects in lymphoid-specific V(D)J recombination. Most patients carry hypomorphic mutations in recombination-activating gene (RAG) 1 or 2. Hematopoietic stem cell transplantation is...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Allergy Clin Immunol
Main Authors: Capo, Valentina, Castiello, Maria Carmina, Fontana, Elena, Penna, Sara, Bosticardo, Marita, Draghici, Elena, Poliani, Luigi P., Sergi Sergi, Lucia, Rigoni, Rosita, Cassani, Barbara, Zanussi, Monica, Carrera, Paola, Uva, Paolo, Dobbs, Kerry, Sacchetti, Nicolò, Notarangelo, Luigi D., van Til, Niek P., Wagemaker, Gerard, Villa, Anna
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6081264/
https://ncbi.nlm.nih.gov/pubmed/29241731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2017.11.015
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares